The DOI matches its Crossref record; 143 of the 143 references it cites were found in a registry or an index.
Matrix Metalloproteinases and Blood-Brain Barrier Disruption in Acute Ischemic Stroke
Open accessAbstract
Ischemic stroke continues to be one of the most challenging diseases in translational neurology. Tissue plasminogen activator (tPA) remains the only approved treatment for acute ischemic stroke, but its use is limited to the first hours after stroke onset due to an increased risk of hemorrhagic transformation over time resulting in enhanced brain injury. In this review we discuss the role of matrix metalloproteinases (MMPs) in blood-brain barrier (BBB) disruption as a consequence of ischemic stroke. MMP-9 in particular appears to play an important role in tPA-associated hemorrhagic complications. Reactive oxygen species can enhance the effects of tPA on MMP activation through the loss of caveolin-1 (cav-1), a protein encoded in the cav-1 gene that serves as a critical determinant of BBB permeability. This review provides an overview of MMPs' role in BBB breakdown during acute ischemic stroke. The possible role of MMPs in combination treatment of acute ischemic stroke is also examined.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Tissue Plasminogen Activator for Acute Ischemic Stroke
(1995) · New England Journal of Medicine · doi:10.1056/nejm199512143332401 · Cited by 11,654
Thrombolysis with Alteplase 3 to 4.5 Hours after Acute Ischemic Stroke
Hacke, W., Kaste, M., Bluhmki, E., Brozman, M., Dávalos, A., Guidetti, D., Larrue, V., Lees, K. R., Medeghri, Z., Machnig, T., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0804656 · Cited by 6,684 · cited 1×
“For acute ischemic stroke, thrombolysis is beneficial for patients if induced during the first 3–4.5 h of symptom onset (NINDS, ECASS III) (National Institute of Neurological Disorders and Stroke rt-PA Stroke Study Group, 1995; Hacke et al., 2008).”
InfluentialStructure and function of the blood–brain barrier
Abbott, N. J., Patabendige, A. A. K., Dolman, D. E. M., Yusof, S. R., & Begley, D. J. (2010) · Neurobiology of Disease · doi:10.1016/j.nbd.2009.07.030 · Cited by 5,185
How Matrix Metalloproteinases Regulate Cell Behavior
Sternlicht, M. D., & Werb, Z. (2001) · Annual Review of Cell and Developmental Biology · doi:10.1146/annurev.cellbio.17.1.463 · Cited by 3,959 · cited 1×
“An alternate classification arranges the MMPs according to their domain structure (Sternlicht and Werb, 2001).”
Ghrelin: Structure and Function
Kojima, M., & Kangawa, K. (2005) · Physiological Reviews · doi:10.1152/physrev.00012.2004 · Cited by 2,810
The blood-brain barrier/neurovascular unit in health and disease
Hawkins, B. T., & Davis, T. P. (2005) · Pharmacological Reviews · doi:10.1124/pr.57.2.4 · Cited by 2,661
Mechanisms, challenges and opportunities in stroke
Lo, E. H., Dalkara, T., & Moskowitz, M. A. (2003) · Nature Reviews Neuroscience · doi:10.1038/nrn1106 · Cited by 1,781
Inflammatory mechanisms in ischemic stroke: role of inflammatory cells
Jin, R., Yang, G., & Li, G. (2010) · Journal of Leukocyte Biology · doi:10.1189/jlb.1109766 · Cited by 1,521
Tissue inhibitors of metalloproteinases: structure, regulation and biological functions.
Gomez, D. E., Alonso, D. F., Yoshiji, H., & Thorgeirsson, U. P. (1997) · PubMed · Cited by 1,508
Endothelial Cell-to-Cell Junctions: Molecular Organization and Role in Vascular Homeostasis
Bazzoni, G., & Dejana, E. (2004) · Physiological Reviews · doi:10.1152/physrev.00035.2003 · Cited by 1,389
Matrix Metalloproteinases: Role In Arthritis
Burrage, P. (2006) · Frontiers in Bioscience · doi:10.2741/1817 · Cited by 1,292
Clark, W. M., Wissman, S., Albers, G. W., Jhamandas, J. H., Madden, K. P., Hamilton, S., & for the ATLANTIS Study Investigators (1999) · JAMA · doi:10.1001/jama.282.21.2019 · Cited by 1,186
Morita, K., Furuse, M., Fujimoto, K., & Tsukita, S. (1999) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.96.2.511 · Cited by 1,126
Yang, Y., Estrada, E. Y., Thompson, J. F., Liu, W., & Rosenberg, G. A. (2007) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600375 · Cited by 1,060
Wardlaw, J. M., Murray, V., Berge, E., del Zoppo, G., Sandercock, P., Lindley, R. L., & Cohen, G. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60738-7 · Cited by 1,010
Asahi, M., Wang, X., Mori, T., Sumii, T., Jung, J.-C., Moskowitz, M. A., Fini, M. E., & Lo, E. H. (2001) · The Journal of Neuroscience · doi:10.1523/jneurosci.21-19-07724.2001 · Cited by 1,004
Recombinant tissue plasminogen activator in acute thrombotic and embolic stroke
del Zoppo, G. J., Poeck, K., Pessin, M. S., Wolpert, S. M., Furlan, A. J., Ferbert, A., Alberts, M. J., Zivin, J. A., Wechsler, L., Busse, O., et al. (1992) · Annals of Neurology · doi:10.1002/ana.410320113 · Cited by 999
Blood-brain barrier tight junction permeability and ischemic stroke
Sandoval, K. E., & Witt, K. A. (2008) · Neurobiology of Disease · doi:10.1016/j.nbd.2008.08.005 · Cited by 964
LRP: a multifunctional scavenger and signaling receptor
Herz, J., & Strickland, D. K. (2001) · Journal of Clinical Investigation · doi:10.1172/jci13992 · Cited by 908
Intracerebral Hemorrhage After Intravenous t-PA Therapy for Ischemic Stroke
The NINDS t-PA Stroke Study Group (1997) · Stroke · doi:10.1161/01.str.28.11.2109 · Cited by 880
Rosenberg, G. A., Estrada, E. Y., & Dencoff, J. E. (1998) · Stroke · doi:10.1161/01.str.29.10.2189 · Cited by 861
Physiology and pathophysiology of matrix metalloproteases
Klein, T., & Bischoff, R. (2011) · Amino Acids · doi:10.1007/s00726-010-0689-x · Cited by 828
Freije, J. M., Díez-Itza, I., Balbín, M., Sánchez, L. M., Blasco, R., Tolivia, J., & López-Otín, C. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)89457-7 · Cited by 762
NXY-059 for the Treatment of Acute Ischemic Stroke
Shuaib, A., Lees, K. R., Lyden, P., Grotta, J., Davalos, A., Davis, S. M., Diener, H.-C., Ashwood, T., Wasiewski, W. W., & Emeribe, U. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa070240 · Cited by 732
Matrix metalloproteinases (MMPs) in health and disease: an overview
Malemud, C. (2006) · Frontiers in Bioscience · doi:10.2741/1915 · Cited by 705
Role of matrix metalloproteinases in delayed cortical responses after stroke
Zhao, B.-Q., Wang, S., Kim, H.-Y., Storrie, H., Rosen, B. R., Mooney, D. J., Wang, X., & Lo, E. H. (2006) · Nature Medicine · doi:10.1038/nm1387 · Cited by 702
NXY-059 for Acute Ischemic Stroke
Lees, K. R., Zivin, J. A., Ashwood, T., Davalos, A., Davis, S. M., Diener, H.-C., Grotta, J., Lyden, P., Shuaib, A., Hårdemark, H.-G., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052980 · Cited by 660
Taddei, A., Giampietro, C., Conti, A., Orsenigo, F., Breviario, F., Pirazzoli, V., Potente, M., Daly, C., Dimmeler, S., & Dejana, E. (2008) · Nature Cell Biology · doi:10.1038/ncb1752 · Cited by 653
Wang, Y. F., Tsirka, S. E., Strickland, S., Stieg, P. E., Soriano, S. G., & Lipton, S. A. (1998) · Nature Medicine · doi:10.1038/nm0298-228 · Cited by 630
A new penumbra: transitioning from injury into repair after stroke
Lo, E. H. (2008) · Nature Medicine · doi:10.1038/nm1735 · Cited by 611
Asahi, M., Asahi, K., Jung, J.-C., del Zoppo, G. J., Fini, M. E., & Lo, E. H. (2000) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200012000-00007 · Cited by 610
Possible Involvement of Phosphorylation of Occludin in Tight Junction Formation
Sakakibara, A., Furuse, M., Saitou, M., Ando-Akatsuka, Y., & Tsukita, S. (1997) · The Journal of Cell Biology · doi:10.1083/jcb.137.6.1393 · Cited by 589
Yepes, M., Sandkvist, M., Moore, E. G., Bugge, T. H., Strickland, D. K., & Lawrence, D. A. (2003) · Journal of Clinical Investigation · doi:10.1172/jci19212 · Cited by 566
Montaner, J., Molina, C. A., Monasterio, J., Abilleira, S., Arenillas, J. F., Ribó, M., Quintana, M., & Alvarez-Sabín, J. (2003) · Circulation · doi:10.1161/01.cir.0000046451.38849.90 · Cited by 555
Chin, J. R., Murphy, G., & Werb, Z. (1985) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)39034-8 · Cited by 495
Gidday, J. M., Gasche, Y. G., Copin, J.-C., Shah, A. R., Perez, R. S., Shapiro, S. D., Chan, P. H., & Park, T. S. (2005) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.01275.2004 · Cited by 483
Larrue, V., von Kummer, R., del Zoppo, G., & Bluhmki, E. (1997) · Stroke · doi:10.1161/01.str.28.5.957 · Cited by 474
Su, E. J., Fredriksson, L., Geyer, M., Folestad, E., Cale, J., Andrae, J., Gao, Y., Pietras, K., Mann, K., Yepes, M., et al. (2008) · Nature Medicine · doi:10.1038/nm1787 · Cited by 468
Lipoprotein receptor–mediated induction of matrix metalloproteinase by tissue plasminogen activator
Wang, X., Lee, S.-R., Arai, K., Lee, S.-R., Tsuji, K., Rebeck, G. W., & Lo, E. H. (2003) · Nature Medicine · doi:10.1038/nm926 · Cited by 460
Plasmin and Matrix Metalloproteinases in Vascular Remodeling
Lijnen, H. R. (2001) · Thrombosis and Haemostasis · doi:10.1055/s-0037-1616230 · Cited by 453
Increased Brain Expression of Matrix Metalloproteinase-9 After Ischemic and Hemorrhagic Human Stroke
Rosell, A., Ortega-Aznar, A., Alvarez-Sabín, J., Fernández-Cadenas, I., Ribó, M., Molina, C. A., Lo, E. H., & Montaner, J. (2006) · Stroke · doi:10.1161/01.str.0000223001.06264.af · Cited by 439
The role of shear stress in Blood-Brain Barrier endothelial physiology
Cucullo, L., Hossain, M., Puvenna, V., Marchi, N., & Janigro, D. (2011) · BMC Neuroscience · doi:10.1186/1471-2202-12-40 · Cited by 438
Liu, J., Jin, X., Liu, K. J., & Liu, W. (2012) · The Journal of Neuroscience · doi:10.1523/jneurosci.6409-11.2012 · Cited by 434
Sumii, T., & Lo, E. H. (2002) · Stroke · doi:10.1161/hs0302.104542 · Cited by 423
Gu, Z., Cui, J., Brown, S., Fridman, R., Mobashery, S., Strongin, A. Y., & Lipton, S. A. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.1563-05.2005 · Cited by 417
Multiple roles for MMPs and TIMPs in cerebral ischemia
Cunningham, L. A., Wetzel, M., & Rosenberg, G. A. (2005) · Glia · doi:10.1002/glia.20169 · Cited by 411
Gasche, Y., Fujimura, M., Morita-Fujimura, Y., Copin, J.-C., Kawase, M., Massengale, J., & Chan, P. H. (1999) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199909000-00010 · Cited by 400
Gasche, Y., Copin, J.-C., Sugawara, T., Fujimura, M., & Chan, P. H. (2001) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200112000-00003 · Cited by 390
Castellanos, M., Leira, R., Serena, J., Pumar, J. M., Lizasoain, I., Castillo, J., & Dávalos, A. (2003) · Stroke · doi:10.1161/01.str.0000046764.57344.31 · Cited by 361
Vasogenic edema due to tight junction disruption by matrix metalloproteinases in cerebral ischemia
Rosenberg, G. A., & Yang, Y. (2007) · Neurosurgical Focus · doi:10.3171/foc.2007.22.5.5 · Cited by 357
Matrix Metalloproteinases in Cerebrovascular Disease
Mun-Bryce, S., & Rosenberg, G. A. (1998) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199811000-00001 · Cited by 348
Castellanos, M., Leira, R., Serena, J. L., Pumar, J. M., Lizasoaín, I., Castillo, J., & Dávalos, A. (2003) · PubMed · Cited by 343
Lapchak, P. A., Chapman, D. F., & Zivin, J. A. (2000) · Stroke · doi:10.1161/01.str.31.12.3034 · Cited by 339
Clark, A. W., Krekoski, C. A., Bou, S.-S., Chapman, K. R., & Edwards, D. R. (1997) · Neuroscience Letters · doi:10.1016/s0304-3940(97)00859-8 · Cited by 328
McColl, B. W., Rothwell, N. J., & Allan, S. M. (2008) · The Journal of Neuroscience · doi:10.1523/jneurosci.2674-08.2008 · Cited by 314
Evidence that tyrosine phosphorylation may increase tight junction permeability
Staddon, J. M., Herrenknecht, K., Smales, C., & Rubin, L. L. (1995) · Journal of Cell Science · doi:10.1242/jcs.108.2.609 · Cited by 310
Montaner, J., Alvarez-Sabín, J., Molina, C. A., Anglés, A., Abilleira, S., Arenillas, J., & Monasterio, J. (2001) · Stroke · doi:10.1161/hs1201.99512 · Cited by 298
TIMP-2 reduces proteolytic opening of blood-brain barrier by type IV collagenase
Rosenberg, G. A., Kornfeld, M., Estrada, E., Kelley, R. O., Liotta, L. A., & Stetler-Stevenson, W. G. (1992) · Brain Research · doi:10.1016/0006-8993(92)90681-x · Cited by 281
Pfefferkorn, T., & Rosenberg, G. A. (2003) · Stroke · doi:10.1161/01.str.0000083051.93319.28 · Cited by 272
Inflammation and ischaemic stroke
Muir, K. W., Tyrrell, P., Sattar, N., & Warburton, E. (2007) · Current Opinion in Neurology · doi:10.1097/wco.0b013e32813ba151 · Cited by 264
Regulated assembly of tight junctions by protein kinase C.
Stuart, R. O., & Nigam, S. K. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.13.6072 · Cited by 262
Justicia, C., Panés, J., Solé, S., Cervera, Á., Deulofeu, R., Chamorro, Á., & Planas, A. M. (2003) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/01.wcb.0000090680.07515.c8 · Cited by 262
Gu, Y., Zheng, G., Xu, M., Li, Y., Chen, X., Zhu, W., Tong, Y., Chung, S. K., Liu, K. J., & Shen, J. (2012) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07542.x · Cited by 251
Horstmann, S., Kalb, P., Koziol, J., Gardner, H., & Wagner, S. (2003) · Stroke · doi:10.1161/01.str.0000088062.86084.f2 · Cited by 251
Activated protein C inhibits tissue plasminogen activator–induced brain hemorrhage
Cheng, T., Petraglia, A. L., Li, Z., Thiyagarajan, M., Zhong, Z., Wu, Z., Liu, D., Maggirwar, S. B., Deane, R., Fernández, J. A., et al. (2006) · Nature Medicine · doi:10.1038/nm1498 · Cited by 248
Minocycline to Improve Neurologic Outcome in Stroke (MINOS): A Dose-Finding Study
Fagan, S. C., Waller, J. L., Nichols, F. T., Edwards, D. J., Pettigrew, L. C., Clark, W. M., Hall, C. E., Switzer, J. A., Ergul, A., & Hess, D. C. (2010) · Stroke · doi:10.1161/strokeaha.110.582601 · Cited by 244
Inflammation and the neurovascular unit in the setting of focal cerebral ischemia
del Zoppo, G. J. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2008.08.028 · Cited by 243
Phosphorylation of Claudin-5 and Occludin by Rho Kinase in Brain Endothelial Cells
Yamamoto, M., Ramirez, S. H., Sato, S., Kiyota, T., Cerny, R. L., Kaibuchi, K., Persidsky, Y., & Ikezu, T. (2008) · The American Journal of Pathology · doi:10.2353/ajpath.2008.070076 · Cited by 241
Kelly, P. J., Morrow, J. D., Ning, M., Koroshetz, W., Lo, E. H., Terry, E., Milne, G. L., Hubbard, J., Lee, H., Stevenson, E., et al. (2008) · Stroke · doi:10.1161/strokeaha.107.488189 · Cited by 238
Planas, A. M., Solé, S., & Justicia, C. (2001) · Neurobiology of Disease · doi:10.1006/nbdi.2001.0435 · Cited by 231
Matrix metalloproteinases and free radicals in cerebral ischemia
Jian Liu, K., & Rosenberg, G. A. (2005) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2005.03.033 · Cited by 230
Gurney, K. J., Estrada, E. Y., & Rosenberg, G. A. (2006) · Neurobiology of Disease · doi:10.1016/j.nbd.2006.02.006 · Cited by 229
Tsuji, K., Aoki, T., Tejima, E., Arai, K., Lee, S.-R., Atochin, D. N., Huang, P. L., Wang, X., Montaner, J., & Lo, E. H. (2005) · Stroke · doi:10.1161/01.str.0000177517.01203.eb · Cited by 228
Barr, T. L., Latour, L. L., Lee, K.-Y., Schaewe, T. J., Luby, M., Chang, G. S., El-Zammar, Z., Alam, S., Hallenbeck, J. M., Kidwell, C. S., et al. (2010) · Stroke · doi:10.1161/strokeaha.109.570515 · Cited by 226
Extension of the Thrombolytic Time Window With Minocycline in Experimental Stroke
Murata, Y., Rosell, A., Scannevin, R. H., Rhodes, K. J., Wang, X., & Lo, E. H. (2008) · Stroke · doi:10.1161/strokeaha.108.514026 · Cited by 224
Matrix Metalloproteinase-9 as a Marker for Acute Ischemic Stroke: A Systematic Review
Ramos-Fernandez, M., Bellolio, M. F., & Stead, L. G. (2011) · Journal of Stroke and Cerebrovascular Diseases · doi:10.1016/j.jstrokecerebrovasdis.2009.10.008 · Cited by 220
Multiphasic roles for matrix metalloproteinases after stroke
ROSELL, A., & LO, E. (2008) · Current Opinion in Pharmacology · doi:10.1016/j.coph.2007.12.001 · Cited by 215 · cited 3×
“Clinical data have also shown that plasma and brain levels of MMP-9 are elevated in patients with acute ischemic stroke, and delayed tPA therapy causes a further increase in plasma MMP9 in stroke patients (Horstmann et al., 2003; Montaner et al., 2003; Rosell et al., 2006; Castellanos et al., 2007; Kelly et al., 2008;…”
Potent and Selective Mechanism-Based Inhibition of Gelatinases
Brown, S., Bernardo, M. M., Li, Z.-H., Kotra, L. P., Tanaka, Y., Fridman, R., & Mobashery, S. (2000) · Journal of the American Chemical Society · doi:10.1021/ja001461n · Cited by 197
Adibhatla, R., & Hatcher, J. (2008) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/187152708784936608 · Cited by 196
Machado, L. S., Kozak, A., Ergul, A., Hess, D. C., Borlongan, C. V., & Fagan, S. C. (2006) · BMC Neuroscience · doi:10.1186/1471-2202-7-56 · Cited by 193
Association between tPA therapy and raised early matrix metalloproteinase-9 in acute stroke
Ning, M., Furie, K. L., Koroshetz, W. J., Lee, H., Barron, M., Lederer, M., Wang, X., Zhu, M., Sorensen, A. G., Lo, E. H., et al. (2006) · Neurology · doi:10.1212/01.wnl.0000216133.98416.b4 · Cited by 182
VE-cadherin: adhesion at arm's length
Vincent, P. A., Xiao, K., Buckley, K. M., & Kowalczyk, A. P. (2004) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00522.2003 · Cited by 180
Asahi, M., Asahi, K., Wang, X., & Lo, E. H. (2000) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-200003000-00002 · Cited by 176
Yamashita, T., Kamiya, T., Deguchi, K., Inaba, T., Zhang, H., Shang, J., Miyazaki, K., Ohtsuka, A., Katayama, Y., & Abe, K. (2009) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2008.164 · Cited by 175
Polavarapu, R., Gongora, M. C., Yi, H., Ranganthan, S., Lawrence, D. A., Strickland, D., & Yepes, M. (2007) · Blood · doi:10.1182/blood-2006-08-043125 · Cited by 174
Chen, F., Ohashi, N., Li, W., Eckman, C., & Nguyen, J. H. (2009) · Hepatology · doi:10.1002/hep.23203 · Cited by 165
Gu, Y. (2011) · Frontiers in Bioscience · doi:10.2741/222 · Cited by 161
Rosell, A., Álvarez‐Sabín, J., Arenillas, J. F., Rovira, À., Delgado, P., Fernández‐Cadenas, I., Peñalba, A., Molina, C. A., & Montaner, J. (2005) · Stroke · doi:10.1161/01.str.0000170641.01047.cc · Cited by 161
Yagi, K., Kitazato, K. T., Uno, M., Tada, Y., Kinouchi, T., Shimada, K., & Nagahiro, S. (2008) · Stroke · doi:10.1161/strokeaha.108.520262 · Cited by 159
Fujimoto, M., Takagi, Y., Aoki, T., Hayase, M., Marumo, T., Gomi, M., Nishimura, M., Kataoka, H., Hashimoto, N., & Nozaki, K. (2008) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2008.59 · Cited by 158
Matrix metalloproteinase 2 gene knockout has no effect on acute brain injury after focal ischemia
Asahi, M., Sumii, T., Fini, M. E., Itohara, S., & Lo, E. H. (2001) · Neuroreport · doi:10.1097/00001756-200109170-00050 · Cited by 158
Stromelysin‐1 (MMP‐3) is critical for intracranial bleeding after t‐PA treatment of stroke in mice
SUZUKI, Y., NAGAI, N., Umemura, K., Collen, D., & LIJNEN, H. R. (2007) · Journal of Thrombosis and Haemostasis · doi:10.1111/j.1538-7836.2007.02628.x · Cited by 152
MMP-Mediated Disruption of Claudin-5 in the Blood–Brain Barrier of Rat Brain After Cerebral Ischemia
Yang, Y. R., & Rosenberg, G. A. (2011) · Methods in molecular biology · doi:10.1007/978-1-61779-185-7_24 · Cited by 150
Switzer, J. A., Hess, D. C., Ergul, A., Waller, J. L., Machado, L. S., Portik‐Dobos, V., Pettigrew, L. C., Clark, W. M., & Fagan, S. C. (2011) · Stroke · doi:10.1161/strokeaha.111.618215 · Cited by 142
Collagenase 2 (MMP-8) Expression in Murine Tissue-remodeling Processes
Balbı́n, M., Fueyo, A., Knäuper, V., Pendás, A. M., López, J. M., Jiménez, M., Murphy, G., & López-Otı́n, C. (1998) · Journal of Biological Chemistry · doi:10.1074/jbc.273.37.23959 · Cited by 141
Lee, C. Z., Xue, Z., Zhu, Y., Yang, G., & Young, W. L. (2007) · Stroke · doi:10.1161/strokeaha.106.481515 · Cited by 139
Choi, J. M., Shin, H. K., Kim, K. Y., Lee, J. H., & Hong, K. W. (2002) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.300.3.787 · Cited by 136
Cui, J., Chen, S., Zhang, C., Meng, F., Wu, W., Hu, R., Hadass, O., Lehmidi, T. E., Blair, G. J., Lee, M., et al. (2012) · Molecular Neurodegeneration · doi:10.1186/1750-1326-7-21 · Cited by 130
Presence of a gelatin-specific proteinase and its latent form in human leucocytes
Sopata, I., & Dancewicz, A. M. (1974) · Biochimica et Biophysica Acta (BBA) - Enzymology · doi:10.1016/0005-2744(74)90112-0 · Cited by 126
Chou, S. H.-Y., Feske, S. K., Simmons, S. L., Konigsberg, R. G., Orzell, S. C., Marckmann, A., Bourget, G., Bauer, D. J., Jager, P. L. D., Du, R., et al. (2011) · Translational Stroke Research · doi:10.1007/s12975-011-0117-x · Cited by 124
Structure and function of the blood-brain barrier
Siti, Y. (2010) · Frontiers in Pharmacology · doi:10.3389/conf.fphar.2010.02.00002 · Cited by 120
Suzuki, Y., Nagai, N., Yamakawa, K., Kawakami, J., LIJNEN, H. R., & Umemura, K. (2009) · Blood · doi:10.1182/blood-2009-02-203919 · Cited by 119
Efficacy of minocycline in acute ischemic stroke: A single-blinded, placebo-controlled trial
Srivastava, M. V. P., Bhasin, A., Bhatia, R., Garg, A. K., Gaikwad, S. B., Prasad, K., Singh, M. B., & Tripathi, M. (2012) · Neurology India · doi:10.4103/0028-3886.93584 · Cited by 119
Abbruscato, T. J., & Davis, T. P. (1999) · Brain Research · doi:10.1016/s0006-8993(99)01778-3 · Cited by 115
Neuroprotective Effects of Overexpressing Tissue Inhibitor of Metalloproteinase TIMP-1
Tejima, E., Guo, S., Murata, Y., Arai, K., Lok, J. M., van Leyen, K., Rosell, A., Wang, X., & Lo, E. H. (2009) · Journal of Neurotrauma · doi:10.1089/neu.2009-0959 · Cited by 114
Green, A., & Ashwood, T. J. (2005) · CNS & Neurological Disorders - Drug Targets · doi:10.2174/1568007053544156 · Cited by 114
Cuadrado, E., Rosell, A., Peñalba, A., SLEVIN, M. A., Álvarez‐Sabín, J., Aznar, A. O., & Montaner, J. (2009) · Journal of Proteome Research · doi:10.1021/pr801012x · Cited by 111
Activation of Matrix Metalloproteinase-3 and Agrin Cleavage in Cerebral Ischemia/Reperfusion
Solé, S., Petegnief, V., Gorina, R., Chamorro, Á., & Planas, A. M. (2004) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/63.4.338 · Cited by 107
Niego, B., Freeman, R., Puschmann, T. B., Turnley, A. M., & Medcalf, R. L. (2012) · Blood · doi:10.1182/blood-2011-07-369512 · Cited by 107
Evaluating therapeutic targets for reperfusion‐related brain hemorrhage
Maier, C. M., Hsieh, L. B., Crandall, T., Narasimhan, P., & Chan, P. H. (2006) · Annals of Neurology · doi:10.1002/ana.20850 · Cited by 103
Different roles of matrix metalloproteinases-2 and -9 after human ischaemic stroke
Lucivero, V., Prontera, M. P., Mezzapesa, D. M., Petruzzellis, M., Sancilio, M., Tinelli, A., Noia, D. D., Ruggieri, M., & Federico, F. (2007) · Neurological Sciences · doi:10.1007/s10072-007-0814-0 · Cited by 101
Jiang, X., Namura, S., & Nagata, I. (2001) · Neuroscience Letters · doi:10.1016/s0304-3940(01)01800-6 · Cited by 97
Lapchak, P. A., Araujo, D. M., Song, D., Wei, J., Purdy, R. H., & Zivin, J. A. (2002) · Stroke · doi:10.1161/01.str.0000017145.22806.aa · Cited by 86
Expression and regulation of collagenase‐3 (MMP‐13) in human malignant tumors
Balbı́n, M., Pendás, A. M., Urı́a, J. A., Jiménez, M., Freije, J. M. P., & López-Otı́n, C. (1999) · Apmis · doi:10.1111/j.1699-0463.1999.tb01525.x · Cited by 86
Harris, A. K., Ergul, A., Kozak, A., Machado, L. S., Johnson, M. H., & Fagan, S. C. (2005) · BMC Neuroscience · doi:10.1186/1471-2202-6-49 · Cited by 85
Tanaka, K., Gotoh, F., Fukuuchi, Y., Amano, T., Uematsu, D., Kawamura, J., Yamawaki, T., Itoh, N., Obara, K., & Muramatsu, K. (1989) · Stroke · doi:10.1161/01.str.20.5.668 · Cited by 84
Chen, T., Lee, M., Chen, H., Kuo, Y., Lin, S., Wu, T., & Lee, E. (2006) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2005.00307.x · Cited by 81
Suofu, Y., Clark, J. F., Broderick, J. P., Kurosawa, Y., Wagner, K. R., & Lu, A. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.03.036 · Cited by 79
Lee, C. Z., Yao, J. S., Huang, Y., Zhai, W., Liu, W., Guglielmo, B. J., Lin, E., Yang, G.-Y., & Young, W. L. (2006) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/sj.jcbfm.9600268 · Cited by 78
Ishiguro, M., Mishiro, K., Fujiwara, Y., Chen, H., Izuta, H., Tsuruma, K., Shimazawa, M., Yoshimura, S., Satoh, M., Iwama, T., et al. (2010) · PLoS ONE · doi:10.1371/journal.pone.0015178 · Cited by 78
Orbe, J., Barrenetxe, J., Rodríguez, J. A., Vivien, D., Orset, C., Parks, W. C., Birkland, T. P., Serrano, R., Purroy, A., de Lizarrondo, S. M., et al. (2011) · Circulation · doi:10.1161/circulationaha.111.047100 · Cited by 68
Mishiro, K., Ishiguro, M., Suzuki, Y., Tsuruma, K., Shimazawa, M., & Hara, H. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2011.12.042 · Cited by 66
Wang, G., Guo, Q., Hossain, M., Fazio, V., Zeynalov, E., Janigro, D., Mayberg, M. R., & Namura, S. (2009) · Brain Research · doi:10.1016/j.brainres.2009.07.070 · Cited by 65
CD47 gene knockout protects against transient focal cerebral ischemia in mice
Jin, G., Tsuji, K., Xing, C., Yang, Y., Wang, X., & Lo, E. H. (2009) · Experimental Neurology · doi:10.1016/j.expneurol.2009.02.004 · Cited by 64
Zloković, B. V. (2006) · Nature Medicine · doi:10.1038/nm0406-390 · Cited by 62
Acute Stroke — On the Threshold of a Therapy?
del Zoppo, G. J. (1995) · New England Journal of Medicine · doi:10.1056/nejm199512143332410 · Cited by 60
Ishiguro, M., Kawasaki, K., Suzuki, Y., Ishizuka, F., Mishiro, K., Egashira, Y., Ikegaki, I., Tsuruma, K., Shimazawa, M., Yoshimura, S., et al. (2012) · Neuroscience · doi:10.1016/j.neuroscience.2012.06.015 · Cited by 59
Williams, P. D., Zloković, B. V., Griffin, J. H., Pryor, K. E., & Davis, T. P. (2012) · Current Pharmaceutical Design · doi:10.2174/138161212802430413 · Cited by 58
Copin, J., Bengualid, D. J., da Silva, R., Kargiotis, O., Schaller, K., & Gasche, Y. (2011) · European Journal of Neuroscience · doi:10.1111/j.1460-9568.2011.07843.x · Cited by 50
Improving potency and selectivity of a new class of non-Zn-chelating MMP-13 inhibitors
Heim‐Riether, A., Taylor, S. J., Liang, S., Gao, D. A., Xiong, Z., August, E. M., Collins, B., Farmer, B. T., Haverty, K., Hill-Drzewi, M., et al. (2009) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2009.07.151 · Cited by 50
Copin, J., Merlani, P. G., Sugawara, T., Chan, P. H., & Gasche, Y. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.05.022 · Cited by 49
Demir, R., Ulvi, H., Özel, L., Özdemir, G., Güzelcik, M., & Aygül, R. (2012) · Acta Neurologica Belgica · doi:10.1007/s13760-012-0067-4 · Cited by 48
Exosite-Dependent Regulation of the Protein C Anticoagulant Pathway
Rezaie, A. R. (2003) · Trends in Cardiovascular Medicine · doi:10.1016/s1050-1738(02)00191-3 · Cited by 46
Tissue-Type Plasminogen Activator
Collen, D. (1986) · Drugs · doi:10.2165/00003495-198631010-00001 · Cited by 44
Tissue‐type Plasminogen Activator
LIJNEN, H. R., & Collen, D. (2008) · Springer eBooks · doi:10.1007/978-3-540-38918-7_6892 · Cited by 44
Goto, H., Fujisawa, H., Oka, F., Nomura, S., Kajiwara, K., Kato, S., Fujii, M., Maekawa, T., & Suzuki, M. (2007) · Journal of Neurotrauma · doi:10.1089/neu.2006.0183 · Cited by 43
Vascular Protection and Restorative Therapy in Ischemic Stroke
Yamashita, T., Deguchi, K., Nagotani, S., & Abe, K. (2010) · Cell Transplantation · doi:10.3727/096368910x532800 · Cited by 38
Casserly, B. P., Gerlach, H., Phillips, G. S., Marshall, J. C., Lemeshow, S. A., & Levy, M. M. (2012) · Critical Care Medicine · doi:10.1097/ccm.0b013e31823e9f45 · Cited by 33
Therapeutic approaches to vascular protection in ischemic stroke.
Yamashita, T., & Abe, K. (2011) · Institutional Repositories DataBase (IRDB) · doi:10.18926/amo/46846 · Cited by 31
Yamashita, T., Kamiya, T., Deguchi, K., Inaba, T., Zhang, H., Shang, J., Miyazaki, K., Ohtsuka, A., Katayama, Y., & Abe, K. (2010) · Okayama Igakkai Zasshi (Journal of Okayama Medical Association) · doi:10.4044/joma.122.195 · Cited by 25
Matrix Metalloproteinase-3 Gene Polymorphisms Are Associated with Ischemic Stroke
Kim, S. K., Kang, S. W., Kim, D. H., Yun, D. H., Chung, J., & Ban, J. Y. (2011) · Journal of Interferon & Cytokine Research · doi:10.1089/jir.2011.0022 · Cited by 20
Stroke Treatment Using Intravenous and Intra-Arterial Tissue Plasminogen Activator
Miller, J. B., Hartwell, C., & Lewandowski, C. (2012) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-012-0176-7 · Cited by 11
Inflammation and Ischemic Stroke
Hao, J., Zheng, K., & Zhao, H. (2018) · Springer series in translational stroke research · doi:10.1007/978-3-319-90194-7_9 · Cited by 3
Cited by
Neuroinflammation: friend and foe for ischemic stroke
Jayaraj, R. L., Azimullah, S., Beiram, R., Jalal, F. Y., & Rosenberg, G. A. (2019) · Journal of Neuroinflammation · doi:10.1186/s12974-019-1516-2 · Cited by 1,428
Signaling pathways involved in ischemic stroke: molecular mechanisms and therapeutic interventions
Qin, C., Yang, S., Chu, Y.-H., Zhang, H., Pang, X.-W., Chen, L., Zhou, L.-Q., Chen, M., Tian, D.-S., & Wang, W. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01064-1 · Cited by 939
Current advances in ischemic stroke research and therapies
Barthels, D., & Das, H. (2020) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2018.09.012 · Cited by 709
Knowland, D., Arac, A., Sekiguchi, K. J., Hsu, M., Lutz, S. E., Perrino, J., Steinberg, G. K., Barres, B. A., Nimmerjahn, A., & Agalliu, D. (2014) · Neuron · doi:10.1016/j.neuron.2014.03.003 · Cited by 703
“derived matrix metalloproteinases (MMPs), release of inflammatory cytokines within the ischemic core or peri-infarct area and secretion of vascular endothelial growth factor (VEGF) have all been postulated to trigger TJ disassembly during reperfusion (Rosenberg and Yang, 2007; Arai et al., 2011; Lakhan et al., 2013).”
Health benefits of resveratrol: Evidence from clinical studies
Singh, A. P., Singh, R., Verma, S. S., Rai, V., Kaschula, C. H., Maiti, P., & Gupta, S. C. (2019) · Medicinal Research Reviews · doi:10.1002/med.21565 · Cited by 523
Metadata
- Authors
- Lakhan, S. E., Kirchgessner, A., Tepper, D., & Leonard, A.
- Venue
- Frontiers in Neurology
- Publisher
- Frontiers Media SA
- Published
- 2013
- Volume
- 4
- Pages
- 32-32
- ISSN
- 1664-2295 (ISSN-L)
- OpenAlex
- W2160213908
- Cited by
- 384
- References
- 143
- FWCI
- 11.89
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.